Keytruda
Funding of cancer drug Keytruda
The Health Minister is promising more funding for Pharmac in the next budget. Audio
Health Minister needs to step up to responsibilities
And listening to that is the Labour leader Andrew Little. Audio
Will the Health Minister front up to melanoma sufferers?
Melanoma patients say the health minister's decision not to publicly fund the drug keytruda has condemned people to death. Audio
Keytruda petitioners head to Parliament
Cancer survivor Leisa Renwick will present a petition to Parliament today calling for the melanoma treatment drug Keytruda to be made available to all New Zealanders who need it. Audio
Pharmac's melanoma treatment 'not ideal'
Pharmac's only melanoma treatment is not ideal for treating the disease, a representative for the government agency has told Checkpoint with John Campbell. Video, Audio
Melanoma patients call for Keytruda funding
Patients suffering from advanced melanoma yesterday called for Pharmac to fund cancer drug Keytruda. Audio
Petition to fund cancer drug to be presented to Pharmac
Nearly 8000 people have signed a petition calling for Pharmac to fund Keytruda, a cancer drug which fights advanced melanoma. Checkpoint speaks to two people with stage four melanoma. Video, Audio
Strugging to Stay Alive with Melanoma
Karen Brown investigates how good the new-generation cancer drugs, such the melanoma treatment Keytruda, really are and if NZ should fund them. Audio
Pharmac won't be swayed on melanoma drug
Pharmac is refusing to be rushed into funding a hotly debated new drug for advanced melanoma.
The media clamour for funding cancer drugs
The government is under pressure to pay for another costly cancer 'wonder drug'. It's not the first time the media have weighed in on how the nation's pharmaceutical budget should be spent, egged on… Audio
The cost of medicines
Dr Chris Jackson of the Cancer Society talks about the costs of drugs here and in other countries. Audio
Pharmac not funding melanoma drug
Dr Chris Jackson of the Cancer Society talks about the impact of Pharmac deciding to not fund a new melanoma drug Keytruda. Audio